STOCK TITAN
  1. Home
  2. News
  3. KRMD

KORU Medical Systems, Inc. - KRMD STOCK NEWS

Welcome to our dedicated page for KORU Medical Systems news (Ticker: KRMD), a resource for investors and traders seeking the latest updates and insights on KORU Medical Systems stock.

KORU Medical Systems, Inc. (symbol: KRMD) is a prominent developer and manufacturer of innovative medical devices and supplies, headquartered at 24 Carpenter Road, Chester, New York, United States. Specializing in mechanical infusion products, the company is renowned for its cutting-edge FREEDOM Infusion Systems. These systems include the FREEDOM60 and FreedomEdge Syringe Drivers, designed to provide efficient and reliable delivery of life-saving therapies.

KORU Medical Systems primarily focuses on subcutaneous infusion devices, which are essential for administering immunoglobulin therapies to patients suffering from chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Their product line features the Precision Flow Rate Tubing and HIgH-Flo Subcutaneous Safety Needle Sets, enhancing the safety and effectiveness of home-based treatments.

The company's commitment to quality and innovation has positioned it as a leader in the medical device industry. Recent achievements include advancements in product technology and expanded partnerships aimed at enhancing patient care and expanding market reach. KORU Medical Systems continues to prioritize patient-centered solutions, ensuring their products meet the highest standards of safety and performance.

News

KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin

Rhea-AI Summary
KORU Medical Systems, Inc. (KRMD) announces a clinical supply agreement for a novel subcutaneous immunoglobulin drug entering Phase 3 trials. The custom product developed aims to treat autoimmune diseases, primary immunodeficiency disorders, and neurological disorders. KORU Medical's advanced device enhances patient comfort and therapy delivery, showcasing their commitment to healthcare innovation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.39%
Tags
clinical trial
-
News

KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024

Rhea-AI Summary
KORU Medical Systems (NASDAQ: KRMD) will report Q4 and full year 2023 financial results on March 13, 2024. The company focuses on subcutaneous infusion solutions. A conference call and webcast will be held to discuss the results and provide a corporate update.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.9%
Tags
conferences earnings
-
News

KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare Conference

Rhea-AI Summary
KORU Medical Systems (NASDAQ: KRMD) will participate in Piper Sandler’s 35th Annual Healthcare Conference on November 29, 2023. The management will present at 1:30 pm ET. Interested parties can access the webcast on the News/Events page of KORU Medical’s website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.55%
Tags
conferences
News

KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023

Rhea-AI Summary
KORU Medical Systems, Inc. (KRMD) to host investor day at headquarters, featuring presentations on key markets, growth strategy, product portfolio, and financial performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.16%
Tags
conferences
-
News

KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System

Rhea-AI Summary
KORU Medical Systems, Inc. (NASDAQ: KRMD) announces a development agreement with a biopharmaceutical manufacturer to create a next-generation infusion system for subcutaneous immunoglobulin (SCIg) therapy, aiming to improve patient experience and facilitate easier home therapy. The collaboration reflects KORU Medical's commitment to providing innovative specialty subcutaneous infusion solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.31%
Tags
none
-
News

KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer

Rhea-AI Summary
KRMD: KORU Medical Systems, Inc. appoints Ken Miller as Chief Commercial Officer, bringing 30+ years of experience in healthcare. Miller's impressive track record includes a successful stint at NASCO Healthcare and Becton Dickinson, with notable achievements in sales & marketing and global expansion. As Chief Commercial Officer, Miller will oversee global sales and marketing, and his appointment comes with two separate options to purchase 200,000 shares of the Company's common stock. KORU Medical's President and CEO, Linda Tharby, expressed confidence in Miller's ability to drive the company's growth and success.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.31%
Tags
management
News

KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 Outlook

Rhea-AI Summary
KORU Medical Systems, Inc. (NASDAQ: KRMD) reported third quarter net revenue of $7.0 million, a 10% decline versus the prior year. The company also updated its full year 2023 outlook, revising net revenue guidance to $28.0 to $28.5 million and reaffirming gross margin guidance between 58%-60% for the full year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.31%
Tags
earnings
-
News

KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60® Infusion System With Hizentra® 50 ML Prefilled Syringes

Rhea-AI Summary
KORU Medical Systems, Inc. (NASDAQ: KRMD) Receives FDA Clearance for FREEDOM60® Infusion System with Hizentra® 50 mL Prefilled Syringes, Expanding Benefits of SCIg Therapy in the Home
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.19%
Tags
clinical trial
-
News

KORU Medical Systems to Participate in Upcoming Investor Conferences

Rhea-AI Summary
KORU Medical Systems (NASDAQ: KRMD) will participate in two upcoming investor conferences: Canaccord MedTech, Diagnostics and Digital Health & Services Forum and the 14th Annual Craig-Hallum Alpha Select Conference, both on November 16th, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.76%
Tags
conferences
News

KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023

Rhea-AI Summary
KORU Medical Systems will report its third quarter 2023 financial results on November 8, 2023. The company will host a conference call and webcast to discuss the results and provide a corporate update.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.86%
Tags
conferences earnings

FAQ

What is the current stock price of KORU Medical Systems (KRMD)?

The current stock price of KORU Medical Systems (KRMD) is $4.02 as of December 20, 2024.

What is the market cap of KORU Medical Systems (KRMD)?

The market cap of KORU Medical Systems (KRMD) is approximately 171.9M.

What does KORU Medical Systems, Inc. specialize in?

KORU Medical Systems specializes in developing and manufacturing mechanical infusion products, particularly the FREEDOM Infusion Systems.

Where is KORU Medical Systems, Inc. located?

The company is based at 24 Carpenter Road, Chester, New York, United States.

What are the primary products of KORU Medical Systems?

The primary products include the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets.

Who benefits from KORU Medical Systems' products?

Patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) benefit from their products.

What recent achievements has KORU Medical Systems accomplished?

Recent achievements include technological advancements in product development and expanding partnerships to enhance patient care and market reach.

What is the FREEDOM Infusion System?

The FREEDOM Infusion System is a mechanical infusion device designed to deliver immunoglobulin therapies efficiently and safely.

Why is KORU Medical Systems considered a leader in the industry?

The company is recognized for its commitment to quality, innovation, and patient-centered solutions in the medical device industry.

What is the focus of KORU Medical Systems' product development?

Their product development focuses on creating subcutaneous infusion devices for home-based treatments.

How does KORU Medical Systems ensure product safety?

The company ensures product safety by maintaining high standards in their design and manufacturing processes.

What kind of partnerships has KORU Medical Systems established?

They have established partnerships aimed at improving patient care services and expanding their market presence.

Stock KRMD logo
KORU Medical Systems, Inc.

Nasdaq:KRMD

KRMD Rankings

#3991 Ranked by Market Cap
N/A Ranked by Dividends

KRMD Stock Data

171.89M
42.95M
6.3%
54.38%
1.06%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
MAHWAH